Robert M. Gill

1.1k total citations
38 papers, 921 citations indexed

About

Robert M. Gill is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Emergency Medicine. According to data from OpenAlex, Robert M. Gill has authored 38 papers receiving a total of 921 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cardiology and Cardiovascular Medicine, 16 papers in Molecular Biology and 8 papers in Emergency Medicine. Recurrent topics in Robert M. Gill's work include Cardiac electrophysiology and arrhythmias (16 papers), Cardiac Arrest and Resuscitation (8 papers) and Cardiac pacing and defibrillation studies (7 papers). Robert M. Gill is often cited by papers focused on Cardiac electrophysiology and arrhythmias (16 papers), Cardiac Arrest and Resuscitation (8 papers) and Cardiac pacing and defibrillation studies (7 papers). Robert M. Gill collaborates with scholars based in United States, Canada and Israel. Robert M. Gill's co-authors include Robert J. Sweeney, Philip R. Reid, Adrian Young, Ryan J. Mailloux, Douglas P. Zipes, Mitchell I. Steinberg, Weiqun Shen, Michael Barber, Timothy Mueller and Ben Davies and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Robert M. Gill

37 papers receiving 906 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert M. Gill United States 19 454 421 163 86 82 38 921
F Papoušek Czechia 17 295 0.6× 319 0.8× 97 0.6× 151 1.8× 117 1.4× 45 848
Chang Yin United States 14 301 0.7× 617 1.5× 377 2.3× 236 2.7× 93 1.1× 18 1.2k
Joshua Strom United States 19 520 1.1× 621 1.5× 39 0.2× 78 0.9× 36 0.4× 40 1.1k
Marian J. Zuidwijk Netherlands 16 325 0.7× 388 0.9× 85 0.5× 158 1.8× 12 0.1× 21 965
Philipp S. Lange Germany 15 395 0.9× 272 0.6× 59 0.4× 93 1.1× 7 0.1× 67 961
C L Seidel United States 20 339 0.7× 423 1.0× 44 0.3× 258 3.0× 15 0.2× 41 1.0k
Bradley K. McConnell United States 25 1.6k 3.4× 1.3k 3.1× 52 0.3× 81 0.9× 30 0.4× 54 2.2k
Tilmann Volk Germany 18 432 1.0× 587 1.4× 28 0.2× 89 1.0× 19 0.2× 41 921
Cathrine Husberg Norway 18 289 0.6× 340 0.8× 46 0.3× 76 0.9× 12 0.1× 23 852
Guangyu Wu United States 11 335 0.7× 519 1.2× 44 0.3× 66 0.8× 18 0.2× 17 783

Countries citing papers authored by Robert M. Gill

Since Specialization
Citations

This map shows the geographic impact of Robert M. Gill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert M. Gill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert M. Gill more than expected).

Fields of papers citing papers by Robert M. Gill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert M. Gill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert M. Gill. The network helps show where Robert M. Gill may publish in the future.

Co-authorship network of co-authors of Robert M. Gill

This figure shows the co-authorship network connecting the top 25 collaborators of Robert M. Gill. A scholar is included among the top collaborators of Robert M. Gill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert M. Gill. Robert M. Gill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Almutairi, Malak, Keshav Gopal, Amanda A. Greenwell, et al.. (2020). The GLP-1 Receptor Agonist Liraglutide Increases Myocardial Glucose Oxidation Rates via Indirect Mechanisms and Mitigates Experimental Diabetic Cardiomyopathy. Canadian Journal of Cardiology. 37(1). 140–150. 58 indexed citations
2.
Gill, Robert M., et al.. (2019). C57BL/6J mice upregulate catalase to maintain the hydrogen peroxide buffering capacity of liver mitochondria. Free Radical Biology and Medicine. 146. 59–69. 24 indexed citations
3.
Gill, Robert M., et al.. (2019). Estimation of the hydrogen peroxide producing capacities of liver and cardiac mitochondria isolated from C57BL/6N and C57BL/6J mice. Free Radical Biology and Medicine. 135. 15–27. 42 indexed citations
5.
Mailloux, Ryan J., et al.. (2018). Simultaneous Measurement of Superoxide/Hydrogen Peroxide and NADH Production by Flavin-containing Mitochondrial Dehydrogenases. Journal of Visualized Experiments. 8 indexed citations
7.
Young, Adrian, Robert M. Gill, & Ryan J. Mailloux. (2018). Protein S-glutathionylation: The linchpin for the transmission of regulatory information on redox buffering capacity in mitochondria. Chemico-Biological Interactions. 299. 151–162. 34 indexed citations
8.
Papagiannakopoulos, Thales, Dinorah Friedmann‐Morvinski, Pierre Neveu, et al.. (2011). Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases. Oncogene. 31(15). 1884–1895. 154 indexed citations
9.
Braz, Julian C., Robert M. Gill, Najia Jin, et al.. (2009). Selective Activation of PI3Kα/Akt/GSK-3β Signalling and Cardiac Compensatory Hypertrophy During recovery from Heart Failure. European Journal of Heart Failure. 11(8). 739–748. 22 indexed citations
10.
Gill, Robert M., et al.. (2007). Restoration of impaired endothelium-dependent coronary vasodilation in failing heart: role of eNOS phosphorylation and CGMP/cGK-I signaling. American Journal of Physiology-Heart and Circulatory Physiology. 292(6). H2782–H2790. 26 indexed citations
11.
Gill, Robert M., Juan Wang, Julian C. Braz, et al.. (2006). Cardiac diastolic dysfunction in conscious dogs with heart failure induced by chronic coronary microembolization. American Journal of Physiology-Heart and Circulatory Physiology. 291(6). H3154–H3158. 21 indexed citations
12.
Shen, Weiqun, et al.. (2004). Sodium channel enhancer restores baroreflex sensitivity in conscious dogs with heart failure. American Journal of Physiology-Heart and Circulatory Physiology. 288(4). H1508–H1514. 7 indexed citations
13.
Shen, Weiqun, et al.. (2002). Combined Inotropic and Bradycardic Effects of a Sodium Channel Enhancer in Conscious Dogs with Heart Failure: A Mechanism for Improved Myocardial Efficiency Compared with Dobutamine. Journal of Pharmacology and Experimental Therapeutics. 303(2). 673–680. 9 indexed citations
15.
Gill, Robert M., Robert J. Sweeney, & Philip R. Reid. (1997). Refractory Period Extension During Ventricular Pacing at Fibrillatory Pacing Rates. Pacing and Clinical Electrophysiology. 20(3). 647–653. 3 indexed citations
16.
Sweeney, Robert J., Robert M. Gill, & Philip R. Reid. (1997). Defibrillation Efficacy Using High‐Frequency Switching to Proportion Current Among Simultaneous Shock Pathways. Journal of Cardiovascular Electrophysiology. 8(3). 271–280. 2 indexed citations
17.
Sweeney, Robert J., Robert M. Gill, Janice L. Jones, & Philip R. Reid. (1996). Defibrillation Using a High‐Frequency Series of Monophasic Rectangular Pulses: Observations and Model Predictions. Journal of Cardiovascular Electrophysiology. 7(2). 134–143. 13 indexed citations
18.
Sweeney, Robert J., Robert M. Gill, Mitchell I. Steinberg, & Philip R. Reid. (1996). Effects of Flecainide, Encainide, and Clofilium on Ventricular Refractory Period Extension by Transcardiac Shocks. Pacing and Clinical Electrophysiology. 19(1). 50–60. 6 indexed citations
19.
Sweeney, Robert J., Robert M. Gill, & Philip R. Reid. (1994). Double‐Pulse Defibrillation Using Pulse Separation Based on the Fibrillation Cycle Length. Journal of Cardiovascular Electrophysiology. 5(9). 761–770. 8 indexed citations
20.
Orlic, Donald, et al.. (1989). Molecular Mechanism for the Inhibitory Action of Interferon on Hematopoiesis. Annals of the New York Academy of Sciences. 554(1). 36–48. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026